NRX Pharmaceuticals
Manufacturing · Delaware, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1201 N Orange St Ste 600, Wilmington, De...Phone Number
(484) 254-6134Website
www.nrxpharma.comRevenue
<$5 MillionStock Symbol
NRXPIndustry
About NRX Pharmaceuticals
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel treatments for central nervous system disorders, including life-threatening forms of depression and post-traumatic stress disorder. It uses a scientific platform targeting the brains NMDA receptor to advance drug candidates such as preservative-free ketamine formulations and oral therapies designed to address unmet needs in severe mental health conditions. The company also supports healthcare delivery through its interventional psychiatry clinic network.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: NRXPShow moreNRX Pharmaceuticals Org Chart
Compare Similar Companies to NRX Pharmaceuticals
Compare insights from companies similar to NRX Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
NRX Pharmaceuticals
<$5M
11-50
Public
$65.9M
2015
SK
Sarah KwartlerOffice of the CEO, Director of Special Projects
NRX Pharmaceuticals Tech Stack
A closer look at the technologies used by NRX Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NRX Pharmaceuticals
Sign Up For FreeTo access detailed company insights
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel treatments for central nervous system disorders, including life-threatening forms of depression and post-traumatic stress disorder. It uses a scientific platform targeting the brains NMDA receptor to advance drug candidates such as pr... Read More